Moneycontrol PRO
HomeNewscompaniesCiti's Anshul Gupta may join Avendus Capital to replace Chintan Kothari who heads to VC firm

Citi's Anshul Gupta may join Avendus Capital to replace Chintan Kothari who heads to VC firm

On February 16, investment firm Eight Roads Ventures announced that Kothari had joined its healthcare team in India as a Partner.

February 16, 2023 / 21:16 IST
Gupta, an IIM-A and IIT-D alumnus, has worked with Citi for nearly 12 years. (Representative Image)

Anshul Gupta, a Managing Director at Citi Investment Banking India, has resigned and is likely to join Avendus Capital, replacing outgoing Managing Director and Head, Healthcare Investment Banking, Chintan Kothari, multiple industry sources with knowledge of the matter told Moneycontrol.

"Anshul has put down his papers at Citi and plans to join Avendus Capital in the next few months," one of the persons mentioned above told Moneycontrol.

Three other persons also told Moneycontrol that the above move was in the works.

All four persons above spoke to Moneycontrol on the condition of anonymity.

Corporate Crossings New Series Logo

Citi and Avendus Capital declined to comment in response to email queries from Moneycontrol. When contacted on the phone, Kothari and Gupta declined to comment.

Also read: KKR-backed Avendus to acquire Spark Capital's institutional equities business

Gupta, an IIM Ahmedabad and IIT Delhi alumnus, has worked with Citi for nearly 12 years. Earlier, worked he with Greenhill & Co, Deutsche Bank and Deloitte Consulting, according to his LinkedIn profile.

Also read: Citi Investment Banking elevates 2 dealmakers as MDs

On February 16, investment firm Eight Roads Ventures announced that Kothari had joined its healthcare team in India as a Partner. In May 2022, the firm launched its first dedicated $250-million healthcare and life sciences fund for India. Kothari, who was at Avendus Capital for nearly seven years, has previously worked with Citi and Rothschild, his LinkedIn profile says.

Also read: Avendus Capital leases four floors in Mumbai’s BKC for Rs 2.4 crore per month for five years

Avendus Capital had advised Advent International (along with Kotak Investment Banking) on the private equity (PE) firm's acquisition of a majority stake in Hyderabad-based listed player Suven Pharmaceuticals from the Jasti family, a transaction that was announced in December.

Note For Readers: Corporate Crossings is a series from Moneycontrol that will focus the lens on important executive movements within companies and in the industry, and capture the exits and new innings of members of India Inc, investment bankers, lawyers, Big 4 professionals, private equity investors, & more.

Ashwin Mohan
first published: Feb 16, 2023 07:54 pm

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Subscribe to Tech Newsletters

  • On Saturdays

    Find the best of Al News in one place, specially curated for you every weekend.

  • Daily-Weekdays

    Stay on top of the latest tech trends and biggest startup news.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347